Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 716 (USA) (Dr. Ito)
· consented 2013-02-12
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild ELECTROCARDIOGRAM ST SEGMENT DEPRESSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-12 (study day 60.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-01 (study day 79.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.